noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

The eRulemaking Program

An Assessment of the Vulnerability of Non-Community Water Systems to[...]
FCC - Federal Communications[...]

WCB Network Change Notification Filed By Verizon VA
City of Los Angeles, CA

Mayor Karen Bass Commends City Council’s Confirmation of Public Works[...]

Healthcare

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

10/31/2024 | Press release | Distributed by Public on 10/30/2024 17:29

VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION FOR CORE PRODUCT SACITUZUMAB TIRUMOTECAN (SAC-TMT) ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION

Sharing and Personal Tools

Please select the service you want to use:

Smartlinks | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | News | Health | Biotechnology | Technology | Biotechnology | Science | Biotechnology | Research | Finance | Security Markets | Security Markets | Company News | Business Announcement | Products and Services | Securities Issuers | Pharmaceutical Companies | Hong Kong Stock Exchange (HKEX)

Back

Download the original document